Syndax Pharmaceuticals, Inc. (SNDX)
17.60
-0.62
(-3.40%)
USD |
NASDAQ |
Oct 02, 16:00
17.62
+0.02
(+0.11%)
After-Hours: 20:00
Syndax Pharmaceuticals Market Cap : 1.569B for Oct. 2, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 02, 2026 | 1.569B |
| October 01, 2026 | 1.624B |
| September 30, 2026 | 1.676B |
| September 29, 2026 | 1.626B |
| September 28, 2026 | 1.592B |
| September 25, 2026 | 1.623B |
| September 24, 2026 | 1.602B |
| September 23, 2026 | 1.573B |
| September 22, 2026 | 1.621B |
| September 21, 2026 | 1.611B |
| September 18, 2026 | 1.571B |
| September 17, 2026 | 1.576B |
| September 16, 2026 | 1.541B |
| September 15, 2026 | 1.613B |
| September 14, 2026 | 1.636B |
| September 11, 2026 | 1.621B |
| September 10, 2026 | 1.678B |
| September 09, 2026 | 1.769B |
| September 08, 2026 | 1.778B |
| September 04, 2026 | 1.833B |
| September 03, 2026 | 1.844B |
| September 02, 2026 | 1.853B |
| September 01, 2026 | 1.792B |
| August 31, 2026 | 1.720B |
| August 28, 2026 | 1.742B |
| Date | Value |
|---|---|
| August 27, 2026 | 1.797B |
| August 26, 2026 | 1.791B |
| August 25, 2026 | 1.776B |
| August 24, 2026 | 1.745B |
| August 21, 2026 | 1.752B |
| August 20, 2026 | 1.761B |
| August 19, 2026 | 1.852B |
| August 18, 2026 | 1.775B |
| August 17, 2026 | 1.762B |
| August 14, 2026 | 1.769B |
| August 13, 2026 | 1.701B |
| August 12, 2026 | 1.765B |
| August 11, 2026 | 1.809B |
| August 10, 2026 | 1.816B |
| August 07, 2026 | 1.819B |
| August 06, 2026 | 1.762B |
| August 05, 2026 | 1.776B |
| August 04, 2026 | 1.701B |
| August 03, 2026 | 1.715B |
| July 31, 2026 | 1.687B |
| July 30, 2026 | 1.725B |
| July 29, 2026 | 1.702B |
| July 28, 2026 | 1.738B |
| July 27, 2026 | 1.817B |
| July 24, 2026 | 1.843B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| ACADIA Pharmaceuticals, Inc. | 3.434B |
| Alnylam Pharmaceuticals, Inc. | 29.38B |
| Savara, Inc. | 987.97M |
| Vericel Corp. | 2.055B |
| Biogen, Inc. | 32.48B |
Market Cap Related Metrics
| PS Ratio | 6.126 |
| Price to Book Value | 103.91 |
| Price | 17.60 |
| Earnings Yield | -14.31% |